Cellyan Biotechnology HKPD Ratios (2024-2026)

NASDAQ HKPD
$0.11 +0.00 (+1.81%)
At close: Oct 19, 2026 · 4:00 PM EDT
Reported Financials

Cellyan Biotechnology Quarterly Ratios

Periods 5 quarters
Latest Mar 2026

Cellyan Biotechnology ratios data for the quarter ended Mar 2026. These financial ratios cover 5 quarters of results from Mar 2024 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Mar2024 Sep2024 Mar2025 Sep2025 Mar2026
Efficiency
Inventory AverageInventory Avg. 0.74M0.56M0.58M0.48M
Assets AverageAssets Avg. 9.41M9.79M9.53M11.24M
Equity AverageEquity Avg. 4.80M5.17M5.07M7.39M
Invested CapitalInvested Cap. 5.59M6.59M6.87M6.83M10.51M
Leverage & Solvency
Debt Ratio 0.150.120.200.180.07
Valuation
Price to BookP/B 5.096.721.39
Enterprise Value 26.13M34.35M13.17M
Market Capitalization 25.38M34.54M13.39M

Cellyan Biotechnology Ratios API

Pull Cellyan Biotechnology's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=HKPD&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY